Gastroesophageal Reflux Clinical Trial
Official title:
Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
Cough is the most common complaint for which patients seek medical attention in the United
States, accounting for approximately 1 billion dollars in health care expenses annually.
Gastroesophageal reflux disease (GERD) is the sole cause of chronic cough in up to 20-40% of
all cases. The majority of these patients with GERD-induced cough have no classic "heartburn"
symptoms, so this important cause of cough can thus be difficult to detect.
Our hypothesis is that changes in exhaled breath condensate (EBC) pH can be used as a
sensitive and non-invasive marker to identify subjects with cough caused by acid reflux.
Gastroesophageal reflux disease (GERD) is the sole cause of chronic cough in up to 20-40% of
all cases, and majority of these patients with GERD-induced cough have no classic "heartburn"
symptoms. This important cause of cough can thus be difficult to detect. Non-invasive
radiologic tests for GERD such as barium swallow is imperfectly sensitive in subjects with
GERD-induced cough. The 24 hour pH probe, which continuously monitors esophageal pH and can
correlate cough events with reflux events, is considered to be the gold standard test.
However, this test is expensive, invasive, and not universally available.
The goal of the current study is to compare simultaneous measurements of esophageal pH with
exhaled breath condensate pH after cough episodes, in patients with symptomatic cough. The
cause of cough will be determined by a standard protocol, which includes 24 hour pH probe
studies, and assessment for asthma, upper airway causes and sinus disease, and medication
effects. All subjects will undergo 24 hour pH monitoring. During this monitoring period, they
press an event button on the pH recording device to indicate a cough episode. After six such
events, they will immediately perform an EBC collection, and EBC pH will subsequently be
analyzed. Differences between pH changes in the group with cough cause by GERD will be
compared to pH measurements in the group with cough but no GERD, to determine the sensitivity
and specificity of pH changes for discriminating between the two groups, and optimal
threshold values for pH changes in EBC.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05561179 -
Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease
|
N/A | |
Withdrawn |
NCT02213887 -
Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
|
Phase 4 | |
Completed |
NCT01946971 -
Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)
|
Phase 1/Phase 2 | |
Recruiting |
NCT01825473 -
Study of Erythromycin in GER-Associated Apnea of the Newborn
|
N/A | |
Completed |
NCT00614536 -
Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period
|
Phase 4 | |
Completed |
NCT00373997 -
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
|
Phase 4 | |
Completed |
NCT00365300 -
Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)
|
Phase 3 | |
Completed |
NCT00284908 -
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00226044 -
Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.
|
Phase 3 | |
Completed |
NCT00567021 -
German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms
|
N/A | |
Completed |
NCT00215787 -
Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease
|
N/A | |
Completed |
NCT00141960 -
Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease
|
Phase 2/Phase 3 | |
Completed |
NCT01167543 -
Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease
|
N/A | |
Completed |
NCT00291746 -
Validation of RDQ Questionnaire
|
Phase 4 | |
Completed |
NCT01048840 -
Natural History of Gastroesophageal Reflux (GER) in Children < 12 Years of Age
|
||
Completed |
NCT00181805 -
Natural History of Gastroesophageal Reflux (GER) in Children and Adolescents
|
||
Terminated |
NCT01281553 -
A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease
|
Phase 4 | |
Completed |
NCT05486169 -
Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy
|
N/A | |
Completed |
NCT04034017 -
Gastroesophageal Reflux Disease Among College Students
|
||
Terminated |
NCT03226054 -
Determining Risk Factors for Successful PPI Weaning
|
N/A |